HEGGIE THERESA — SEC Form 4 filings
SEC reporting owner CIK 1760020. 7 Form 4 filings on record with FilingPulse; latest filed 2026-06-15.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-03-04 to 2026-06-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 3 legs across 3 filings — 126,631 shares, $1,141,615 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
- Largest priced transaction: sale of 70,000 shares @ $8.51 ($595,868) in BIOCRYST PHARMACEUTICALS INC, filed 2025-08-15.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| BIOCRYST PHARMACEUTICALS INC (BCRX) | Director | 7 | — | 3 legs · 126,631 sh · $1,141,615 | 14 |
Form 4 filings — HEGGIE THERESA
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-15 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/award (A): 15,294 @ $0 · Grant/award (A): 33,540 (derivative) @ $0 | EDGAR |
| 2026-03-24 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Option exercise (M): 49,933 @ $6.30 · Sale (S): 49,933 @ $10.11 · Option exercise (M): 49,933 (derivative) @ $0 | EDGAR |
| 2025-08-15 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Option exercise (M): 30,000 @ $2.91 · Option exercise (M): 40,000 @ $5.41 · Sale (S): 70,000 @ $8.51 · Option exercise (M): 30,000 (derivative) @ $0 · Option exercise (M): 40,000 (derivative) @ $0 | EDGAR |
| 2025-06-16 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/award (A): 12,500 @ $0 · Grant/award (A): 27,181 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/award (A): 6,820 @ $0 · Sale (S): 6,698 @ $6.11 · Grant/award (A): 49,933 (derivative) @ $0 | EDGAR |
| 2024-06-03 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/award (A): 870 @ $6.46 | EDGAR |
| 2024-03-04 | 4 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/award (A): 999 @ $5.63 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1760020 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →